Case study from Spotlight series

Supporting quality in national cardiovascular registries

16 June, 2020

The European Society of Cardiology has recently launched a project to support the development of compatible national registries for monitoring the quality of cardiovascular care.

European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart) will develop an IT system and data infrastructure that participating countries can use to continually collect data on people living with cardiovascular diseases, including heart failure. The aim of this project is to support ongoing quality improvement in cardiovascular care across Europe.

During the first two years of the programme, the system will be piloted in two to four countries. Wider roll-out is anticipated following this first phase.

References

Wallentin L, Gale CP, Maggioni A, et al. 2019. EuroHeart: European Unified Registries On Heart Care Evaluation and Randomized Trials. Eur Heart J 40(33): 2745-49

European Society of Cardiology. Creating Europe’s largest continuous cardiovascular registry: EuroHeart. [Updated 03/09/19]. Available from: https://www.escardio.org/Congresses-&-Events/ESC-Congress/Congress-resources/Congress-news/creating-europe-s-largest-continuous-cardiovascular-registry-euroheart [Accessed 30/03/20]

Back to the Project
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .